Dopamine D2 receptor agonists abrogate neuroendocrine tumour angiogenesis to inhibit chemotherapy-refractory small cell lung cancer progression
Sk. Kayum Alam(Indian Institute of Chemical Biology), Luke H. Hoeppner(University of Minnesota)
Cited by 9
Related Papers
DNA damage-induced ephrin-B2 reverse signaling promotes chemoresistance and drives EMT in colorectal carcinoma harboring mutant p53
|Cell Death and Differentiation|2015|99
DARPP-32 and t-DARPP promote non-small cell lung cancer growth through regulation of IKKα-dependent cell migration
|Communications Biology|2018|37
ASCL1-regulated DARPP-32 and t-DARPP stimulate small cell lung cancer growth and neuroendocrine tumour cell proliferation
|British Journal of Cancer|2020|34
Lef1ΔN Binds β-Catenin and Increases Osteoblast Activity and Trabecular Bone Mass
|Journal of Biological Chemistry|2011|28
Suppressing STAT3 activity protects the endothelial barrier from VEGF-mediated vascular permeability
|bioRxiv (Cold Spring Harbor Laboratory)|2020|12